Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Review Which Crypto Strategies Are Low Risk, focusing on capital preservation, diversification, and disciplined rebalancing.
27,978 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
SpaceX has sparked huge investor curiosity, but buying SpaceX stock before the next move requires a disciplined plan....
Looking for growth you can ride for years? This guide breaks down three powerhouse names—NVIDIA, Microsoft, and Alpha...
On March 4, 2026, the stock market live march narrative centers on a flat S&P 500 as investors weigh escalating Middl...
A single Tuesday remark from a prominent political figure can ripple through the markets. This article explains what ...
President Trump touts a plan for a government-backed insurance agency to cover Gulf shipping against political risk. ...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...
As the market eyes a 4.5% yield from the LQD ETF, investors should scrutinize BBB credit risk and rate sensitivity th...
A 70,000-seat return in a government-backed venue stirs more than cheers. This article breaks down the money side of ...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...